DeepMed Research

CSA MEDICAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Holding

Established: 1993-01-01

Employees: 51

Market Cap: -

Website: http://www.rejuvenair.com

Clinical Trials

RejuvenAir® System Trial for COPD With Chronic Bronchitis

Not Applicable

Active, not recruiting

Conditions: Chronic Bronchitis

Interventions: Device: RejuvenAir System
Device: Sham Control Procedure

First Posted Date: 2019-03-28

Last Posted Date: 2024-06-03

Lead Sponsor: CSA Medical, Inc.

Target Recruit Count: 210

Registration Number: NCT03893370

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Johns Hopkins Universtiy, Baltimore, Maryland, United States
🇺🇸
Louisiana State University Medical Center, Shreveport, Louisiana, United States

and more 24 locations

Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

Not Applicable

Active, not recruiting

Conditions: COPD
Chronic Bronchitis

Interventions: Device: RejuvenAir System
Other: Sham

First Posted Date: 2019-03-27

Last Posted Date: 2024-02-23

Lead Sponsor: CSA Medical, Inc.

Target Recruit Count: 32

Registration Number: NCT03892694

Locations: 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇬🇧
The Royal Brompton Hospital, London, United Kingdom

Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients

Not Applicable

Completed

Conditions: Cryotherapy Effect
Bronchitis, Chronic

Interventions: Device: RejuvenAir

First Posted Date: 2015-06-29

Last Posted Date: 2023-02-23

Lead Sponsor: CSA Medical, Inc.

Target Recruit Count: 30

Registration Number: NCT02483637

Locations: 🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada
🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇬🇧
Chelsea and Westminster Hosptial/Royal Brompton Hosptial, London, United Kingdom

RejuvenAir Lobectomy for Safety and Histology

Phase 1

Completed

Conditions: Lung Neoplasms
Pulmonary Neoplasms

Interventions: Device: RejuvenAir

First Posted Date: 2015-06-26

Last Posted Date: 2017-05-11

Lead Sponsor: CSA Medical, Inc.

Target Recruit Count: 6

Registration Number: NCT02483052

Locations: 🇨🇦
William Osler Health System, Brampton, Ontario, Canada

RejuvenAir™ System Lobectomy Safety and Histology Study

Not Applicable

Completed

Conditions: Lung Cancer
Lung Neoplasms
Airway Obstruction

Interventions: Device: RejuvenAir™ Radial Spray Cryotherapy

First Posted Date: 2014-04-08

Last Posted Date: 2017-05-11

Lead Sponsor: CSA Medical, Inc.

Target Recruit Count: 11

Registration Number: NCT02106143

Locations: 🇮🇪
Galway University Hosptial, Galway, Ireland
🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇬🇧
Royal Brompton Hospital, London, United Kingdom

TruFreeze™ Airway Obstruction: TAO STUDY

Phase 4

Withdrawn

Conditions: Airway; Obstruction, With Emphysema
Lung Disease Airways
Lung Diseases, Obstructive
Airway Obstruction

Interventions: Device: spray cryotherapy

First Posted Date: 2013-07-19

Last Posted Date: 2016-02-02

Lead Sponsor: CSA Medical, Inc.

Registration Number: NCT01903850

A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy

Not Applicable

Terminated

Conditions: Barrett's Esophagus

Interventions: Device: trūFreeze™ Spray Cryotherapy

First Posted Date: 2013-05-03

Last Posted Date: 2016-04-29

Lead Sponsor: CSA Medical, Inc.

Target Recruit Count: 36

Registration Number: NCT01845454

Locations: 🇺🇸
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
🇺🇸
Columbia University, New York, New York, United States
🇺🇸
University of North Carolina, Chapel Hill, Chapel Hil, North Carolina, United States

and more 3 locations

CryoSpray Ablation(tm)Thoracic Patient Registry

Withdrawn

Conditions: Lung Cancer
Asthma
Sarcoidosis
Chronic Bronchitis
Emphysema
COPD
Mesothelioma

First Posted Date: 2008-11-05

Last Posted Date: 2015-06-25

Lead Sponsor: CSA Medical, Inc.

Registration Number: NCT00785239

CryoSpray Ablation(TM)to Determine Safety and Feasibility in Radiation Induced Proctitis

Phase 4

Withdrawn

Conditions: Radiation Proctitis
Radiation Induced Proctitis

Interventions: Device: Cryo Spray Ablation Group 1
Device: Cryo Spray Ablation Group 2

First Posted Date: 2008-09-22

Last Posted Date: 2015-08-07

Lead Sponsor: CSA Medical, Inc.

Registration Number: NCT00756197

Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.

Phase 4

Completed

Conditions: Barrett's Esophagus
Esophageal Cancer

Interventions: Device: Cryo Spray Ablation

First Posted Date: 2008-09-18

Last Posted Date: 2015-11-04

Lead Sponsor: CSA Medical, Inc.

Target Recruit Count: 7

Registration Number: NCT00754468

Locations: 🇺🇸
University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy